Amlexanox

Amlexanox

Systematic (IUPAC) name
2-amino-7-isopropyl-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxylic acid
Clinical data
Trade names	Aphthasol
AHFS/Drugs.com	monograph
MedlinePlus	a601017
Pregnancy cat.	?
Legal status	?
Routes	Topical
Pharmacokinetic data
Half-life	3.5 hours
Excretion	Renal (17%)
Identifiers
CAS number	68302-57-8 Y
ATC code	A01AD07 R03DX01
PubChem	CID 2161
DrugBank	APRD00795
ChemSpider	2076 Y
UNII	BRL1C2459K Y
KEGG	D01828 Y
ChEBI	CHEBI:31205 Y
ChEMBL	CHEMBL1096 Y
Chemical data
Formula	C16H14N2O4
Mol. mass	298.293 g/mol
SMILES	eMolecules & PubChem
InChI InChI=1S/C16H14N2O4/c1-7(2)8-3-4-12-9(5-8)13(19)10-6-11(16(20)21)14(17)18-15(10)22-12/h3-7H,1-2H3,(H2,17,18)(H,20,21) Y Key:SGRYPYWGNKJSDL-UHFFFAOYSA-N Y
N(what is this?)  (verify)

Amlexanox (trade name Aphthasol) is a medication with antiallergic and anti-inflammatory effects used in the treatment of aphthous ulcers (canker sores). Amlexanox is also available in Japan as oral tablets (trade name Solfa) for treatment of bronchial asthma, where it has been marketed by the Takeda Pharmaceutical Company since 1987, though Aphthtab by Egyptian Eva pharma also exist. In India it is available as Lexanox by Macleods Pharmaceuticals Ltd. In Bangladesh it is marketed by Square Pharmaceuticals as Apsol.

External links

• Information about the use against aphthous ulcers
• Information from Takeda
• Aphthasol